Litcius/Paper detail

EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy

Arsela Prelaj, Sara Elena Rebuzzi, Pamela Pizzutilo, Massimo Bilancia, Michele Montrone, Francesco Pesola, Vito Longo, Gabriella Del Bene, Vittoria Lapadula, Flavio Cassano, Patrizia Petrillo, D. Bafunno, N. Varesano, V. Lamorgese, A. Mastrandrea, D. Ricci, Annamaria Catino, Domenico Galetta

2020Clinical Lung Cancer80 citationsDOI

Topics & Concepts

MedicineLung cancerImmunotherapyOncologyInternal medicineCancerCancer immunotherapyInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersLung Cancer Research Studies
EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy | Litcius